Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
DOCK8 enforces immunological tolerance by promoting IL-2 signaling and immune synapse formation in Tregs
Erin Janssen, Sudha Kumari, Mira Tohme, Sumana Ullas, Victor Barrera, Jeroen M.J. Tas, Marcela Castillo-Rama, Roderick T. Bronson, Shariq M. Usmani, Darrell J. Irvine, Thorsten R. Mempel, Raif S. Geha
Erin Janssen, Sudha Kumari, Mira Tohme, Sumana Ullas, Victor Barrera, Jeroen M.J. Tas, Marcela Castillo-Rama, Roderick T. Bronson, Shariq M. Usmani, Darrell J. Irvine, Thorsten R. Mempel, Raif S. Geha
View: Text | PDF
Research Article Immunology

DOCK8 enforces immunological tolerance by promoting IL-2 signaling and immune synapse formation in Tregs

  • Text
  • PDF
Abstract

Patients deficient in the guanine nucleotide exchange factor DOCK8 have decreased numbers and impaired in vitro function of Tregs and make autoantibodies, but they seldom develop autoimmunity. We show that, similarly, Dock8–/– mice have decreased numbers and impaired in vitro function of Tregs but do not develop autoimmunity. In contrast, mice with selective DOCK8 deficiency in Tregs develop lymphoproliferation, autoantibodies, and gastrointestinal inflammation, despite a normal percentage and in vitro function of Tregs, suggesting that deficient T effector cell function might protect DOCK8-deficient patients from autoimmunity. We demonstrate that DOCK8 associates with STAT5 and is important for IL-2–driven STAT5 phosphorylation in Tregs. DOCK8 localizes within the lamellar actin ring of the Treg immune synapse (IS). Dock8–/– Tregs have abnormal TCR-driven actin dynamics, decreased adhesiveness, an altered gene expression profile, an unstable IS with decreased recruitment of signaling molecules, and impaired transendocytosis of the costimulatory molecule CD86. These data suggest that DOCK8 enforces immunological tolerance by promoting IL-2 signaling, TCR-driven actin dynamics, and the IS in Tregs.

Authors

Erin Janssen, Sudha Kumari, Mira Tohme, Sumana Ullas, Victor Barrera, Jeroen M.J. Tas, Marcela Castillo-Rama, Roderick T. Bronson, Shariq M. Usmani, Darrell J. Irvine, Thorsten R. Mempel, Raif S. Geha

×

Figure 2

Mice with Treg-specific DOCK8 deficiency develop weight loss, splenomegaly, and lymphadenopathy.

Options: View larger image (or click on image) Download as PowerPoint
Mice with Treg-specific DOCK8 deficiency develop weight loss, splenomega...
(A) Weights between age 10 and 30 weeks in Foxp3YFP–Cre/Dock8flox/flox mice and Foxp3YFP–Cre controls. n = 11 Foxp3YFP–Cre/Dock8flox/flox and 10 Foxp3YFP–Cre mice. (B) Serum amyloid P levels in Foxp3YFP–Cre/Dock8flox/flox mice and Foxp3YFP–Cre controls at 28 weeks of age. (C) Hemoglobin concentration and mean red blood cell volume (MCV) in Foxp3YFP–Cre/Dock8flox/flox mice and Foxp3YFP–Cre controls at 12 and 28 weeks of age. (D and E) Representative photographs of the spleens (D), cervical LNs (CLN), and inguinal LNs (ILN) (E) from 30-week-old Foxp3YFP–Cre/Dock8flox/flox mice and Foxp3YFP–Cre controls. (F) Nucleated cells counts, CD4+ cell counts, percentage of CD69+ cells among CD4+ cells, and percentage of CD4+CD44–CD62Lhi naive and CD4+CD44+CD62Llo memory T cells among CD4+FOXP3– cells in the spleens of 30-week-old Foxp3YFP–Cre/Dock8flox/flox mice and Foxp3YFP–Cre controls. (G) Cytokine mRNA expression in pooled CLNs and ILNs from 30-week-old Foxp3YFP–Cre/Dock8flox/flox mice and Foxp3YFP–Cre controls. Results of the qPCR analysis were expressed as fold increase relative to control of the cytokine mRNA/b2microglobulin mRNA ratio. (H) Representative FACS plots showing intracellular cytokine expression after gating on CD4+ T cells stimulated for 3.5 hours with phorbol 12,13-dibutyrate and ionomycin. (I) Serum IgA and IgE levels in 28-week-old Foxp3YFP–Cre/Dock8flox/flox mice and Foxp3YFP–Cre controls. Symbols represent individual mice, and error bars in A–C, F, G, and I represent mean and SEM. t test, NS P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts